======= ZRANB1 ======= == Gene Information == * **Official Symbol**: ZRANB1 * **Official Name**: zinc finger RANBP2-type containing 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=54764|54764]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9UGI0|Q9UGI0]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ZRANB1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ZRANB1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/611749|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Specifically hydrolyzes 'Lys-29'-linked and 'Lys-33'- linked diubiquitin. Also cleaves 'Lys-63'-linked chains, but with 40-fold less efficiency compared to 'Lys-29'-linked ones. Positive regulator of the Wnt signaling pathway that deubiquitinates APC protein, a negative regulator of Wnt-mediated transcription. Plays a role in the regulation of cell morphology and cytoskeletal organization. Required in the stress fiber dynamics and cell migration. May also modulate TNF-alpha signaling. {ECO:0000269|PubMed:18281465, ECO:0000269|PubMed:21834987, ECO:0000269|PubMed:22157957, ECO:0000269|PubMed:23827681}. |OTU| |protein K33-linked deubiquitination| |protein K29-linked deubiquitination| |protein deubiquitination involved in ubiquitin-dependent protein catabolic process| |K63-linked polyubiquitin modification-dependent protein binding| |protein K63-linked deubiquitination| |thiol-dependent ubiquitinyl hydrolase activity| |thiol-dependent ubiquitin-specific protease activity| |positive regulation of Wnt signaling pathway| |protein deubiquitination| |protein modification by small protein removal| |cell-cell signaling by wnt| |Wnt signaling pathway| |regulation of Wnt signaling pathway| |cell surface receptor signaling pathway involved in cell-cell signaling| |regulation of cell morphogenesis| |ubiquitin-dependent protein catabolic process| |modification-dependent protein catabolic process| |modification-dependent macromolecule catabolic process| |proteolysis involved in cellular protein catabolic process| |cellular protein catabolic process| |protein catabolic process| |intracellular membrane-bounded organelle| |cellular macromolecule catabolic process| |cell migration| |protein modification by small protein conjugation or removal| |macromolecule catabolic process| |organonitrogen compound catabolic process| |regulation of anatomical structure morphogenesis| |cell motility| |localization of cell| |cytoskeleton organization| |cell-cell signaling| |proteolysis| |locomotion| |movement of cell or subcellular component| |positive regulation of signal transduction| |organic substance catabolic process| |cellular catabolic process| |positive regulation of cell communication| |positive regulation of signaling| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp38|Wortmannin 5μM R00 exp38]]|-2.28| |[[:results:exp452|Azithromycin 100μM R08 exp452]]|-1.76| |[[:results:exp311|2-Methoxyestradiol 0.55 to 0.75μM on day4 R07 exp311]]|1.79| |[[:results:exp310|2-Methoxyestradiol 0.55μM R07 exp310]]|1.82| |[[:results:exp84|UM0125461 0.74μM R02 exp84]]|1.95| ^Gene^Correlation^ |[[:human genes:h:hectd1|HECTD1]]|0.461| |[[:human genes:m:med13l|MED13L]]|0.42| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 6916 * **Expression level (log2 read counts)**: 5.71 {{:chemogenomics:nalm6 dist.png?nolink |}}